 |
SPECIAL REPORT – VIOXX
Now that there is no question that Merck & Co. knew that taking Vioxx over an extended period of time could lead to serious health risks, patients must be vigilant about protecting their health and their futures.
The dramatic withdrawal of Vioxx, the extremely popular and profitable drug manufactured by Merck & Co., raises many serious questions about the accountability of this pharmaceutical company. The popular arthritis drug was being used by more than a million Americans when the company revealed that studies linked its use with increased risk for cardiovascular disease. This dangerous drug was on the market for FIVE years - - even though warning bells went off several years ago.
Rick Nemeroff has defended many patients who have been injured by dangerous drugs. Unfortunately, Vioxx is just one in a long series of pharmaceutical products that have hurt and even killed patients who put their trust in big pharmaceutical companies. For information about how you can protect yourself and your family, call Rick Nemeroff at 1-888-NEM-LAW-1 or complete this online contact form.
Since the drug was first made available to the general public in 1999, more than 20 million Americans have used Vioxx for varying amounts of time. In September 2001 the FDA sent a warning letter to Merck about the company’s hard-hitting ad campaign, directed towards patients, not doctors.
The letter indicated that the advertising copy gave short shrift to “the potentially serious cardiovascular findings that were observed” in a clinical trial that compared Vioxx to naproxen, a generic and considerably less-expensive painkiller. The FDA was not pleased with Merck’s discounting the fact that "patients on Vioxx were observed to have a four to five-fold increase" in heart attacks, compared with patients on naproxen. The FDA knew there was a problem – and so did Merck.
Vioxx is a non-steroidal, anti-inflammatory drug (NSAID) is a member of a group of drugs referred to as "Cox-2 Inhibitors". It was taken in liquid or pill form, and is used to relieve the symptoms of osteoarthritis. It was also used to treat acute pain in adults. Vioxx worked by blocking COX-2 enzymes in the body that trigger pain and inflammation.
In the past, Merck flatly denied any possible links between Vioxx and cardiovascular problems. But when a clinical trial sponsored by Merck itself found that patients taking a low dose of Vioxx for more than 18 months were twice as likely to have a heart attack or stroke as those taking a placebo, the denial had to end.
Not only has extended use of Vioxx been proven to lead to increased risk of heart attack and stroke, but patients who took Vioxx are also more likely to experience intestinal damage, ulcerations and bleeding, blood clots and toxic epidermal necrolysis (a fatal skin disease), than those taking other arthritis pain relievers.
Vioxx has been proven to cause or contribute to the following life threatening injuries:
- Heart Attacks
- Strokes
- Kidney problems, including the possibility of acute kidney failure.
- Liver problems.
- Allergic reactions (swelling of the face, lips, tongue, and throat)
- Non-bacterial type of meningitis.
If you or a loved one has taken Vioxx, it is possible that your cardiovascular health may be at risk. For more information, contact Rick Nemeroff at 1-888-NEM-LAW-1 or complete this online contact form. We will respond to your inquiry.
|
 |

 |
Hear Rick discuss his techniques and the changing trends of trial preparation
Click Here

Rick Nemeroff's cutting edge technology and trial techniques
Read about Rick's cutting edge technology and trial techniques in the latest edition of the Sanction by Verdict Systems Newsletter.
Rick Nemeroff will co-chair "Toxic Tort Update."
Rick Nemeroff will co-chair “Toxic Tort Update: Texas” Conference hosted by LexisNexis & Mealeys Publications. Litigation topics to be covered include: Asbestos, Silica, Welding Rods, Benzene and more. The conference will be held March 9-10, 2006. Click here for more details.
Rick Nemeroff won a $10,309,000 verdict in Los Angeles, CA on behalf of an 82 year old Navy veteran who is suffering from an asbestos-related mesothelioma. The jury's April 6, 2005 verdict included a finding that punitive damages were also warranted, but the case settled moments before that phase of the trial was to begin.
Rick Nemeroff to speak at National Asbestos Conference on May 5, 2005
Click Here for more information.
Rick Nemeroff appears on CourtTV
Rick appeared on Closing Arguments, hosted by Nancy Grace, to offer his insight and thoughts on a multi-million dollar lawsuit that CourtTV was covering. The episode aired nationwide on January 3, 2005.
VIOXX ALERT
Click here for our special report on Vioxx. Contact Us us Immediately if you or a loved one took Vioxx!
BEXTRA ALERT
Click here for surprising new information about Bextra. Contact Us Immediately if you or a loved one took Bextra!
$10,309,000 - Rick Nemeroff won a verdict in Los Angeles, CA on behalf of an 82 year old Navy veteran who is suffering from an asbestos-related mesothelioma.
$115,000 - Rick Nemeroff won the first Fen Phen trial ever to go to a verdict in the State of California.
$64 Million - Four workers exposed to asbestos in New York.
$55.5 Million Construction worker in Texas exposed to asbestos, develops mesothelioma
$17 Million Seven iron foundry workers exposed to asbestos in Texas
$14 Million Employee exposed to asbestos in New York.
$12.6 Million Pipefitter at Brooklyn Navy Yard develops mesothelioma after exposure to asbestos
$10.4 Million New York workers at powerhouses exposed to asbestos, develop mesothelioma
$9.4 Million Oil refinery workers exposed to toxic chemicals in Baton Rouge, LA
$6.4 Million - Steel plant employee in Cleveland, Ohio exposed to asbestos
$6 Million Worker in Texas exposed to toxic chemicals
|
 |
|